Skip to content
Open access

Fractionation of Terminalia mantaly stem bark extract enhanced antimicrobial, antibiofilm, and antioxidant activities: In vitro and multi-target in silico evaluation.

Nov 2026 · Fitoterapia · pp. 107544 · 0 citations
Medicine

Abstract

Antimicrobial resistance remains a significant global threat, leading to a high mortality rate and the need for alternative treatments. This study aimed to determine the antimicrobial and antioxidant properties of liquid-liquid fractions from Terminalia mantaly stem bark extract and to investigate their potential multi-target interactions using in silico approaches. DPPH, ABTS, and FRAP assays, and cytotoxicity on Vero cells, were performed. The most active fractions were further evaluated for time-kill kinetics, antibiofilm activities, scanning electron microscopy (SEM), and liquid chromatography-mass spectrometry profiling, followed by molecular docking, molecular dynamics (MD) simulations, quantum-chemical calculations, and pharmacokinetics and toxicity profiling. Five fractions (F1-F5) showed minimum inhibitory concentrations ranging from 62.5 to 1000 μg/mL. Staphylococcus aureus ATCC43300 and Candida albicans ATCC14516 were the most susceptible strains, with F4 and F5 showing the highest activity against bacteria and F1 and F3 against yeast. The highest antioxidant activity was obtained with F1 against DPPH (IC50 of 237.4 μg/mL), F4 against FRAP (IC50 of 22.69 μg/mL), and F5 against ABTS radicals (IC50 of 23.46 μg/mL). SEM analysis indicated that the fractions disrupted the membrane and caused lysis of S. aureus. LC-MS profiling revealed 26 metabolites, with CNP0326236 and 6DTA identified as leads against AgrA, CrtM, and SarA. These findings suggest that modulation of quorum sensing, virulence factor expression, and cellular integrity may contribute to the observed antibacterial activity; however, these proposed mechanisms require experimental validation. Further studies, including mechanistic investigations and in vivo validation, are necessary to establish the antimicrobial potential of the identified lead compounds.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.